CellBios Healthcare & Lifesciences

Executive Summary

CellBios Healthcare & Lifesciences is a San Diego-based private medical technology company founded in 2015, specializing in single-use solutions for cell, gene, and tissue therapies (CGT), bioprocessing, and medical fluid administration. The company is a pioneer in cryopreservation bag systems and offers a comprehensive portfolio of sterile fluid transfer and storage bags that support critical workflows from cord blood banking to biomanufacturing and clinical infusion. With the CGT market projected to grow rapidly, CellBios is positioned to benefit from increasing demand for high-quality, disposable fluid management systems that ensure sterility and integrity in sensitive therapeutic processes. Despite being privately held and early-stage in terms of disclosed financials, the company's focused product line and established presence in the biologics supply chain suggest steady commercial traction. However, the competitive landscape includes larger players like Sartorius and Thermo Fisher, which may limit market share expansion. Overall, CellBios represents a niche opportunity in the CGT enabling technology space, with potential for growth driven by innovation and partnerships.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation cryopreservation bag with enhanced cell viability70% success
• 2026Strategic partnership with a top-tier cell therapy developer for exclusive supply50% success
• Q4 2026FDA 510(k) clearance for a novel medical fluid administration bag80% success